Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1Phase 2 1

Status

Completed 4Unknown 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 4CNS 1

Conditions

Uveal Melanoma 4Retinal Diseases 1Melanoma 1Macular Edema 1Glaucoma, Neovascular 1

Interventions

Ipilimumab 123pembrolizumab 101Nivolumab 100aldesleukin 89Cyclophosphamide 85fludarabine phosphate 64Interleukin-2 58Dacarbazine 573-ingenyl angelate 42Vemurafenib 39Temozolomide 39Imiquimod 39trametinib 37sargramostim 37Peripheral Blood Stem Cell Transplantation 36incomplete Freund's adjuvant 35dabrafenib 32fludarabine 31Radiotherapy 31Aminolevulinic Acid 30Bevacizumab 29Carboplatin 28Whole-Body Irradiation 25Photochemotherapy 25Paclitaxel 25Filgrastim 25Biopsy 25Interferon-alpha 24Cisplatin 23Sorafenib 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Ranibizumab × Dermatologic × Clear all
NCT00680225 2017-04-12

Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma

New England Retina Associates

Phase 3 Completed
10 enrolled 4 charts
Dermatologic

Uveal Melanoma

NCT00765921 2016-12-02

Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma

Massachusetts Eye and Ear Infirmary

Phase 1 Completed
40 enrolled
Dermatologic

Uveal Melanoma, Macular Edema, Glaucoma, Neovascular

NCT01251978 2016-10-19

Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma (Cohort 2)

New England Retina Associates

Phase 2 Completed
10 enrolled 7 charts
Dermatologic

Uveal Melanoma

NCT00750399 2012-04-26

Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma

The New York Eye Cancer Center

Phase 1 Completed
10 enrolled
Dermatologic

Uveal Melanoma, Melanoma, Retinal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡